Silexion Therapeutics (SLXN) Times Interest Earned (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Times Interest Earned of -$47.4 for Q1 2026, down 144.16% year-over-year from $107.32 in Q1 2025, and down 330.21% quarter-over-quarter from $20.59 in Q4 2025.
Silexion Therapeutics (SLXN) Times Interest Earned (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Times Interest Earned history runs 4 years deep, the most recent figure standing at -$47.4 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 144.16% year-over-year to -$47.4; the TTM figure through Mar 2026 stood at -$424.37 (down 263.58% YoY), while the FY2025 annual figure was -$1.18, up 35.2% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$47.4, down from $20.59 in the prior quarter.
- The five-year high for Times Interest Earned was $109.73 in Q3 2025, with the low at -$47.4 in Q1 2026.
- The 4-year median for Times Interest Earned is -$6.86 (2024), against an average of $0.96.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned plunged 309.94% in 2024, then surged 5319.02% in 2025.
- Silexion Therapeutics' Times Interest Earned stood at -$6.28 in 2023, then soared by 107.44% to $0.47 in 2024, then jumped by 4304.92% to $20.59 in 2025, then tumbled by 330.21% to -$47.4 in 2026.
- Business Quant data shows SLXN's Times Interest Earned at -$47.4 in Q1 2026, $20.59 in Q4 2025, and $109.73 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Silexion Therapeutics | 266,692.97 | -1.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.53 |
| Mar 31, 2026 | -47.40 |
| Dec 31, 2025 | 20.59 |
| Sep 30, 2025 | 109.73 |
| Jun 30, 2025 | -10.57 |
| Mar 31, 2025 | -19.41 |
| Dec 31, 2024 | 0.47 |
| Sep 30, 2024 | -2.10 |
| Jun 30, 2024 | -12.82 |
| Mar 31, 2024 | -7.44 |
| Dec 31, 2023 | -6.28 |
| Sep 30, 2023 | -10.15 |
| Jun 30, 2023 | -3.13 |